Page last updated: 2024-09-05

colistimethate sodium and pipemidic acid

colistimethate sodium has been researched along with pipemidic acid in 1 studies

Compound Research Comparison

Studies
(colistimethate sodium)
Trials
(colistimethate sodium)
Recent Studies (post-2010)
(colistimethate sodium)
Studies
(pipemidic acid)
Trials
(pipemidic acid)
Recent Studies (post-2010) (pipemidic acid)
188121402693237

Protein Interaction Comparison

ProteinTaxonomycolistimethate sodium (IC50)pipemidic acid (IC50)
exodeoxyribonuclease V subunit RecBEscherichia coli str. K-12 substr. MG16550.1
exodeoxyribonuclease V subunit RecCEscherichia coli str. K-12 substr. MG16550.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K1

Trials

1 trial(s) available for colistimethate sodium and pipemidic acid

ArticleYear
Combination of pipemidic acid, colistin sodium methanesulfonate and nystatin may be less effective than nystatin alone for prevention of infection during chemotherapy-induced granulocytopenia in acute leukemia.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Colistin; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Leukemia; Middle Aged; Nicotinic Acids; Nystatin; Pipemidic Acid; Pneumonia; Random Allocation

1989